Palomar (PLMR) Expected to Announce Quarterly Earnings on Wednesday

Palomar (NASDAQ:PLMR) is anticipated to release its Q4 2025 results before the market opens on Wednesday, February 11th. Analysts expect the company to announce earnings of $2.06 per share and revenue of $204.58 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 12, 2026 at 12:00 PM ET.

Palomar Price Performance

Shares of PLMR opened at $126.54 on Tuesday. The company’s 50-day moving average is $127.87 and its 200-day moving average is $123.16. The firm has a market capitalization of $3.35 billion, a PE ratio of 19.74 and a beta of 0.44. Palomar has a fifty-two week low of $107.75 and a fifty-two week high of $175.85.

Insider Buying and Selling at Palomar

In other news, insider Jonathan Knutzen sold 290 shares of the company’s stock in a transaction on Saturday, January 31st. The stock was sold at an average price of $121.74, for a total transaction of $35,304.60. Following the completion of the sale, the insider directly owned 27,248 shares in the company, valued at approximately $3,317,171.52. This represents a 1.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Angela L. Grant sold 260 shares of the firm’s stock in a transaction on Saturday, January 31st. The stock was sold at an average price of $121.75, for a total value of $31,655.00. Following the completion of the transaction, the insider owned 7,033 shares in the company, valued at $856,267.75. The trade was a 3.57% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 58,998 shares of company stock valued at $7,255,669 over the last ninety days. 3.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Palomar

Several institutional investors and hedge funds have recently bought and sold shares of the company. California State Teachers Retirement System increased its holdings in Palomar by 0.4% in the 2nd quarter. California State Teachers Retirement System now owns 24,207 shares of the company’s stock valued at $3,734,000 after buying an additional 97 shares during the period. NewEdge Advisors LLC boosted its position in shares of Palomar by 49.2% during the 2nd quarter. NewEdge Advisors LLC now owns 713 shares of the company’s stock worth $110,000 after acquiring an additional 235 shares in the last quarter. Captrust Financial Advisors raised its position in Palomar by 6.0% during the second quarter. Captrust Financial Advisors now owns 6,900 shares of the company’s stock valued at $1,064,000 after purchasing an additional 390 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Palomar by 4.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,542 shares of the company’s stock worth $1,231,000 after purchasing an additional 423 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co increased its stake in shares of Palomar by 1.9% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 26,901 shares of the company’s stock valued at $4,147,000 after purchasing an additional 490 shares during the last quarter. Institutional investors own 90.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on PLMR shares. Wall Street Zen cut shares of Palomar from a “buy” rating to a “hold” rating in a report on Saturday. Keefe, Bruyette & Woods upped their target price on Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research report on Tuesday, January 6th. JPMorgan Chase & Co. lifted their price target on Palomar from $145.00 to $155.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Weiss Ratings raised Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, January 14th. Finally, Evercore ISI started coverage on Palomar in a research report on Monday. They set an “outperform” rating and a $150.00 price objective on the stock. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $158.14.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.